{"disease":{"id":"newly-diagnosed-glioblastoma","name":"newly diagnosed glioblastoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03345095","title":"A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":749,"lead_sponsor_name":"European Organisation for Research and Treatment of Cancer - EORTC","has_results":true},{"nct_id":"NCT05163080","title":"SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":247,"lead_sponsor_name":"MimiVax, LLC","has_results":false},{"nct_id":"NCT07021339","title":"Anterior Temporal Lobectomy in Temporal Glioblastoma","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":178,"lead_sponsor_name":"University Hospital, Bonn","has_results":false},{"nct_id":"NCT04600817","title":"A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"TJ Biopharma Co., Ltd.","has_results":false},{"nct_id":"NCT05447195","title":"Phase 2 Study of CAN008 in Subjects With GBM","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":117,"lead_sponsor_name":"CANbridge Life Sciences Ltd.","has_results":false},{"nct_id":"NCT04840069","title":"Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","has_results":false},{"nct_id":"NCT06816927","title":"Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":92,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT01805453","title":"Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04477200","title":"Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"University of Michigan Rogel Cancer Center","has_results":false},{"nct_id":"NCT01790503","title":"A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Daiichi Sankyo","has_results":true},{"nct_id":"NCT03782415","title":"Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"MediciNova","has_results":false},{"nct_id":"NCT03463265","title":"Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Aadi Bioscience, Inc.","has_results":true},{"nct_id":"NCT06649851","title":"G-CSF After Chemo-radiation in Patients With Glioblastoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT01591577","title":"Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05734560","title":"D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Darell Bigner","has_results":false},{"nct_id":"NCT05739942","title":"Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05235737","title":"The Assessment of Immune Response in Newly Diagnosed Glioblastoma Patients Treated With Pembrolizumab","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Medical University of Silesia","has_results":false},{"nct_id":"NCT06622434","title":"New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04488783","title":"Potentiation of Chemotherapy in Brain Tumors by Zinc","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT03619239","title":"Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Genexine, Inc.","has_results":false},{"nct_id":"NCT04474353","title":"Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT04216329","title":"Selinexor (KPT-330) in Combination With Temozolomide and Radiation Therapy in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":11,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT07143812","title":"A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"CHA University","has_results":false},{"nct_id":"NCT04218019","title":"Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Juergen Debus","has_results":false},{"nct_id":"NCT04065087","title":"Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Genexine, Inc.","has_results":false}],"total":25},"guidelines":[],"source":"Drug Landscape verified database"}